TOUJEO
NDC 0024-5869, insulin glargine, injection, solution, from Sanofi-Aventis U.S. LLC.
- Product NDC
- 0024-5869
- Status
- Listed
- Labeler
- Sanofi-Aventis U.S. LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA206538
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0024-5869 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN GLARGINE300 U/mL
Pharmacologic classes
Insulin Analog [EPC]; Insulin [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0024-5869-00 | 00024586900 | 1 SYRINGE in 1 CARTON (0024-5869-00) / 1.5 mL in 1 SYRINGE |
| 0024-5869-03 | 00024586903 | 3 SYRINGE in 1 CARTON (0024-5869-03) / 1.5 mL in 1 SYRINGE (0024-5869-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c9561d96-124d-48ca-982f-0aa1575bff36NADAC price for package 00024586903
GET /v1/drugs/nadac/00024586903
Use it
Look up 0024-5869 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0024-5869 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0024-5869. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.